Target intelligence / Profile preview

Mesoderm development LDL receptor chaperone (MESD)

Target
MESD
Molecular classification
Other (Endoplasmic reticulum protein chaperone; not a receptor, enzyme, transporter, or ion channel)
01

Overview

MESD (Mesoderm development LDL receptor chaperone) is a specialized endoplasmic reticulum chaperone that is essential for folding and maturation of low-density lipoprotein receptor (LDLR) family members, particularly the canonical Wnt co-receptors LRP5 and LRP6[1][2][3]. MESD ensures proper formation of the β-propeller/EGF modules in these proteins, enabling their export to the plasma membrane. MESD is critical for embryonic development, as it is essential for mesoderm induction, embryonic polarity, and for postnatal functions including bone formation and neuromuscular junction development[1][3]. The protein contains distinct chaperone and escort domains, allowing it to both template correct receptor folding and escort properly assembled complexes out of the ER[2]. Loss of MESD function causes severe developmental and metabolic defects due to misfolding and ER retention of target LDL receptors, particularly affecting the Wnt/β-catenin signaling axis[1][2][3][4]. No drugs are currently known to target MESD directly. The gene is associated with rare forms of osteogenesis imperfecta and possibly other developmentally-linked diseases[3].

Other names
KIAA0081MESDC2MESDMUNQ1911/PRO4369BOCAMesoderm development candidate 2Mesoderm development proteinRenal carcinoma antigen NY-REN-61OI20LDLR chaperone MESD
02

Biological functions

Protein folding (specialized chaperone for beta-propeller/EGF modules of LDL receptor family)Embryonic polarity and mesoderm inductionModulation of Wnt signaling pathway via LRP5/6 folding and traffickingNeuromuscular junction formation (via LRP4 surface expression)Regulation of ossification
03

Disease associations

Osteogenesis imperfecta (rare bone fragility disorder)Developmental disorders (embryonic polarity and mesoderm defects in knockout models)
04

Safety considerations

Loss-of-function mutations in MESD cause developmental failure and bone dysplasia in animal models[3][1]Loss of MESD activity disrupts LRP5/6/4 expression, affecting Wnt signaling and embryonic development[1][2]

Beyond the preview

Go deeper on Mesoderm development LDL receptor chaperone (MESD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mesoderm development LDL receptor chaperone (MESD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call